“The first question families ask me is ‘what’s the success rate?’ and I understand why they need a number,” says Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist at Phuket Island Rehab. “But quoting a single statistic without context is misleading. Addiction is a chronic relapsing condition, like type 2 diabetes or hypertension. We do not ask ‘what is the success rate of blood pressure medication?’ as if one course of pills should produce permanent normotension. The right question is: what combination of treatment intensity, duration, and follow-up produces the best long-term outcomes? That question has clear answers.”
Why a Single “Success Rate” Is Misleading
The challenge with rehab success statistics begins with the definition of success. Different studies use different endpoints: programme completion, abstinence at 30 days, abstinence at 12 months, reduction in substance use (even if not total abstinence), improvement in employment, reduction in criminal justice involvement, or improvement in physical and mental health markers. Each of these is a valid outcome, and each produces a different number.
Compounding this problem is selection bias. Studies that report high success rates often draw from populations with health insurance, stable housing, family support, and first-time treatment admissions, factors that independently predict better outcomes regardless of the specific programme. Studies that report low success rates often include emergency-department referrals, court-mandated patients, and individuals with severe co-occurring mental health disorders and unstable housing. Comparing these populations produces statistics that say more about who entered treatment than about whether treatment works.
The most rigorous evidence comes from randomised controlled trials and large longitudinal cohort studies that follow patients for at least 12 months after treatment completion. These consistently show that structured treatment produces outcomes significantly better than no treatment, and that the magnitude of improvement is dose-dependent: more treatment, delivered over a longer period, with more robust aftercare, produces better results.
What the Research Actually Shows
| Outcome Measure | Typical Range | Key Modifiers |
|---|---|---|
| Programme completion (residential) | 50 to 70% | Higher with voluntary admission, family involvement, adequate length of stay |
| Abstinence at 1 year (completers with aftercare) | 40 to 60% | Higher with 90+ day programmes, MAT for opioid use, active aftercare |
| Significant reduction in use (not necessarily abstinence) | 60 to 80% | Broader definition of success captures harm reduction improvements |
| Relapse at some point after treatment | 40 to 60% | Comparable to relapse rates for hypertension (50-70%) and asthma (50-70%) |
| Improvement in employment, health, legal status | Documented in all major longitudinal studies | Occurs even in patients who relapse, if treatment episode was adequate |
The 40 to 60 per cent relapse rate is often cited as evidence that rehab “doesn’t work.” This interpretation reflects a fundamental misunderstanding of chronic disease management. The National Institute on Drug Abuse (NIDA) has long drawn the comparison to other chronic conditions: type 1 diabetes has a medication non-adherence rate of 30 to 50 per cent, hypertension has a treatment relapse rate of 50 to 70 per cent, and asthma has a similar range. No one concludes from these figures that insulin, antihypertensives, or inhalers “don’t work.” Relapse is a feature of chronic conditions, not a failure of a specific treatment episode.
What Makes Rehab More Effective: The Evidence-Based Factors
Treatment Duration
This is the single most consistent predictor of long-term outcomes in addiction treatment research. NIDA’s Principles of Drug Addiction Treatment state that treatment lasting less than 90 days has limited effectiveness, and that significantly better outcomes are associated with longer durations. The DATOS (Drug Abuse Treatment Outcome Studies) project, one of the largest longitudinal studies of treatment effectiveness, found that patients who stayed in residential treatment for 90 days or more were significantly more likely to be abstinent at one-year follow-up than those who left before the 90-day mark. This finding has been replicated across substances, demographics, and treatment modalities.
Evidence-Based Therapeutic Modalities
Not all therapy is equally effective. The modalities with the strongest evidence base for substance use disorders include cognitive behavioural therapy (CBT), which has the largest body of randomised controlled trial evidence; dialectical behaviour therapy (DBT), particularly for patients with co-occurring borderline personality traits or emotional dysregulation; motivational interviewing (MI), which is most effective in early engagement and ambivalence resolution; and contingency management, which uses tangible incentives to reinforce abstinence and has some of the strongest effect sizes in the literature. Programmes that integrate multiple evidence-based modalities produce better outcomes than those relying on a single approach.
Medical Detox and Medication-Assisted Treatment
For opioid use disorder, medication-assisted treatment (MAT) with buprenorphine or methadone approximately doubles the one-year retention rate compared to behavioural treatment alone. For alcohol use disorder, naltrexone and acamprosate have demonstrated efficacy in reducing relapse rates. Medical detox as the entry point to treatment ensures that the acute withdrawal phase is managed safely, reducing early dropout and medical complications.
Aftercare and Continuing Support
The transition from residential treatment back to the real world is the highest-risk period for relapse. Structured aftercare programmes that include ongoing therapy, peer support groups, regular check-ins, and relapse prevention planning significantly improve long-term outcomes. The MATCH (Matching Alcoholism Treatments to Client Heterogeneity) study and subsequent research have shown that active aftercare engagement is one of the strongest independent predictors of sustained recovery at one and five years.
When Substance Use Has Become More Than Occasional
If you are researching rehab success rates, you are almost certainly doing so because you or someone you care about is considering treatment. The fact that you are weighing the evidence is itself a positive sign: informed decision-making leads to better treatment engagement, and better engagement is one of the most reliable predictors of positive outcomes.
The DSM-5 criteria for substance use disorder identify eleven symptoms, including tolerance, withdrawal, use in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, and continued use despite negative consequences. Meeting two or three criteria indicates a mild disorder; six or more indicates a severe disorder. The presence of withdrawal symptoms or tolerance, which often prompt the search for treatment information, each count as a criterion.
At Phuket Island Rehab, treatment is structured around the evidence-based principles that the research identifies as most effective: adequate duration, individualised therapeutic planning, medical detox as the safe starting point, integration of CBT, mindfulness-based approaches, and structured aftercare that extends support well beyond the residential phase.
Summary
There is no single “success rate” for rehab because success is not a binary outcome and addiction is not an acute illness with a cure. The evidence shows that structured treatment significantly improves outcomes compared to no treatment, that longer treatment durations produce substantially better results, that evidence-based modalities (CBT, DBT, MI, contingency management) outperform unstructured approaches, and that aftercare is as important as the residential phase itself. Relapse rates of 40 to 60 per cent are comparable to those of other chronic medical conditions and do not indicate treatment failure. They indicate the need for ongoing management, which is exactly how modern addiction medicine conceptualises recovery.
“I stopped quoting a single success rate years ago,” says Dr. Ponlawat Pitsuwan. “Instead, I tell families what the research tells us: the right treatment, for enough time, with the right follow-up, works. And ‘works’ does not mean perfection. It means measurable, sustained improvement in the person’s health, relationships, and ability to live without the substance controlling their decisions. That is what we design programmes to achieve, and it is what the data shows structured treatment delivers.”
Frequently Asked Questions
What percentage of people stay sober after rehab?
Among individuals who complete a residential programme and actively engage in aftercare, 40 to 60 per cent maintain abstinence at one year. This figure improves with treatment duration beyond 90 days, use of medication-assisted treatment for opioid or alcohol use disorders, and consistent aftercare involvement. Conversely, individuals who leave treatment early or do not engage in aftercare have significantly lower rates of sustained abstinence.
Why do so many people relapse after rehab?
Relapse is common because addiction involves long-term neuroadaptive changes, particularly in the dopamine reward system, prefrontal cortex, and stress circuits, that do not fully reverse during a single treatment episode. Environmental cues, stress, and co-occurring mental health conditions can trigger cravings that overwhelm newly learned coping strategies. Relapse is not a moral failure; it is a clinical event that indicates the treatment plan needs adjustment, just as a blood pressure spike in a hypertensive patient indicates the need for medication review.
Is 30 days of rehab enough?
For most people with moderate to severe substance use disorder, 30 days is not sufficient. NIDA research consistently shows that treatment lasting fewer than 90 days has limited long-term effectiveness. A 30-day programme can manage acute withdrawal and begin therapeutic work, but the neuroplastic changes required for sustained recovery, including D2 receptor upregulation, prefrontal cortical strengthening, and new habit consolidation, require substantially more time.
Does rehab work for alcoholism?
Yes. Large-scale studies including MATCH and UKATT have demonstrated that structured treatment for alcohol use disorder produces significant improvements in abstinence rates, drinking days, health outcomes, and quality of life. The addition of medications such as naltrexone or acamprosate further improves outcomes. Success rates are highest when treatment includes medical detox, evidence-based therapy, adequate duration, and aftercare.
How many times does the average person go to rehab?
There is no single “average” because the number of treatment episodes varies enormously by substance, severity, co-occurring conditions, and access to care. SAMHSA data shows that many people achieve sustained recovery after a single treatment episode, particularly with adequate duration and aftercare, while others require multiple episodes. Each treatment episode, even if followed by a relapse, tends to produce incremental improvement and is associated with better long-term outcomes than no treatment at all.
What is the best type of rehab programme?
The best programme is one matched to the individual’s clinical needs. For severe substance use disorders, residential treatment of 90 days or more with medical detox, evidence-based therapy (CBT, DBT, MI), and structured aftercare has the strongest evidence base. For milder disorders, intensive outpatient programmes can be effective. The critical factors are not the programme’s branding but its clinical components: does it offer medical detox, use evidence-based modalities, provide adequate duration, and include aftercare planning?
Related Reading
You may also find these articles helpful: how addiction rehab actually works step by step, how many times the average person goes to rehab, the four stages of addiction recovery, and what evidence-based addiction treatment means.
Sources
National Institute on Drug Abuse (NIDA). “Principles of Drug Addiction Treatment: A Research-Based Guide.” Third Edition. nida.nih.gov
Substance Abuse and Mental Health Services Administration (SAMHSA). “Treatment Episode Data Set (TEDS).” samhsa.gov
National Health Service (NHS). “Drug Addiction: Getting Help.” nhs.uk
Rehab success rate · addiction treatment outcomes · relapse rate · chronic relapsing condition · NIDA · SAMHSA · DATOS · Project MATCH · cognitive behavioural therapy · dialectical behaviour therapy · motivational interviewing · contingency management · medication-assisted treatment · buprenorphine · naltrexone · acamprosate · methadone · D2 receptor recovery · prefrontal cortex · DSM-5 substance use disorder · aftercare · relapse prevention · 90-day treatment